Showing 1 - 12 results of 12 for search 'Bolette Hartmann', query time: 0.04s Refine Results
  1. 1
    A Pilot Study Examining the Relationship among Crohn Disease Activity, Glucagon-Like Peptide-2 Signalling and Intestinal Function in Pediatric Patients

    A Pilot Study Examining the Relationship among Crohn Disease Activity, Glucagon-Like Peptide-2 Signalling and Intestinal Function in Pediatric Patients by David L Sigalet, Dragan Kravarusic, Decker Butzner, Bolette Hartmann, Jens J Holst, Jon Meddings

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain

    Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain by Lasse Hartmann Schmidt, Jesper Stensig Aa, Bolette Hartmann, Gunvor Iben Madsen, Niels Qvist, Mark Bremholm Ellebæk

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy

    Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy by Nora Hedbäck, Nora Hedbäck, Morten Hindsø, Morten Hindsø, Kirstine N. Bojsen-Møller, Adelaide K. Linddal, Nils B. Jørgensen, Carsten Dirksen, Andreas Møller, Viggo B. Kristiansen, Bolette Hartmann, Bolette Hartmann, Jens J. Holst, Jens J. Holst, Maria S. Svane, Maria S. Svane, Maria S. Svane, Sten Madsbad

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial

    Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial by Mads N. Thomsen, Mads J. Skytte, Amirsalar Samkani, Arne Astrup, Mogens Fenger, Jan Frystyk, Jan Frystyk, Bolette Hartmann, Bolette Hartmann, Jens J. Holst, Jens J. Holst, Thomas M. Larsen, Sten Madsbad, Faidon Magkos, Jens F. Rehfeld, Steen B. Haugaard, Thure Krarup, Thure Krarup

    Published 2022-08-01
    Get full text
    Article
  5. 5
    Comparable Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Basal Fuel Metabolism and Insulin Sensitivity in Individuals with Obesity and Type 2 Diabetes

    Comparable Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Basal Fuel Metabolism and Insulin Sensitivity in Individuals with Obesity and Type 2 Diabetes by Katrine Brodersen, Michael F. Nielsen, Bjørn Richelsen, Esben S. Lauritzen, Einar Pahle, Jan Abrahamsen, Bolette Hartmann, Jens J. Holst, Niels Møller

    Published 2022-01-01
    Get full text
    Article
  6. 6
    The Severity of DSS-Induced Colitis Is Independent of the SCFA-FFAR2/3-GLP-1 Pathway Despite SCFAs Inducing GLP-1 Secretion via FFAR2/3

    The Severity of DSS-Induced Colitis Is Independent of the SCFA-FFAR2/3-GLP-1 Pathway Despite SCFAs Inducing GLP-1 Secretion via FFAR2/3 by Jenna Elizabeth Hunt, Charlotte Bayer Christiansen, Mohammad Yassin, Bolette Hartmann, Stefan Offermanns, Lars Ove Dragsted, Jens Juul Holst, Hannelouise Kissow

    Published 2024-07-01
    Get full text
    Article
  7. 7
    Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion

    Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion by Nicolai J. Wewer Albrechtsen, Simon Veedfald, Astrid Plamboeck, Carolyn F. Deacon, Bolette Hartmann, Filip K. Knop, Tina Vilsboll, Jens J. Holst

    Published 2016-01-01
    Get full text
    Article
  8. 8
    A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans

    A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans by Anne Nissen, Simone Marstrand, Kirsa Skov‐Jeppesen, Lasse Bremholm, Mads Hornum, Ulrik B Andersen, Jens Juul Holst, Mette Marie Rosenkilde, Bolette Hartmann

    Published 2019-10-01
    Get full text
    Article
  9. 9
    Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

    Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study by Bolette Hartmann, Jens Juul Holst, Rahim Mohammad Naimi, Mark Krogh Hvistendahl, Lise Margrete Thomassen, Hanna Johnsen, Charlotte Bayer Christiansen, Palle Bekker Jeppesen

    Published 2021-10-01
    Get full text
    Article
  10. 10
    Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial

    Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial by Katrine Brodersen, Maike Mose, Ulla Ramer Mikkelsen, Jens Otto Lunde Jørgensen, Michael Festersen Nielsen, Niels Møller, Anne‐Marie Wegeberg, Christina Brock, Bolette Hartmann, Jens Juul Holst, Nikolaj Rittig

    Published 2022-09-01
    Get full text
    Article
  11. 11
    Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes

    Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes by Pamela Bowman, Kashyap A Patel, Timothy J McDonald, Jens J Holst, Bolette Hartmann, Maria Leveridge, Beverley M Shields, Suzie Hammersley, Steve R Spaull, Bridget A Knight, Sarah E Flanagan, Maggie H Shepherd, Rob C Andrews, Andrew T Hattersley

    Published 2023-12-01
    Get full text
    Article
  12. 12
    Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy

    Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy by Sasha A.S. Kjeldsen, Lise L. Gluud, Mikkel P. Werge, Julie S. Pedersen, Flemming Bendtsen, Kleopatra Alexiadou, Tricia Tan, Signe S. Torekov, Eva W. Iepsen, Nicole J. Jensen, Michael M. Richter, Jens P. Goetze, Jørgen Rungby, Bolette Hartmann, Jens J. Holst, Birgitte Holst, Joachim Holt, Finn Gustafsson, Sten Madsbad, Maria S. Svane, Kirstine N. Bojsen-Møller, Nicolai J. Wewer Albrechtsen

    Published 2023-11-01
    Get full text
    Article

Search Tools: